Erik Portelius

14.5k total citations · 2 hit papers
144 papers, 9.2k citations indexed

About

Erik Portelius is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Erik Portelius has authored 144 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Physiology, 64 papers in Molecular Biology and 42 papers in Psychiatry and Mental health. Recurrent topics in Erik Portelius's work include Alzheimer's disease research and treatments (117 papers), Dementia and Cognitive Impairment Research (41 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers). Erik Portelius is often cited by papers focused on Alzheimer's disease research and treatments (117 papers), Dementia and Cognitive Impairment Research (41 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers). Erik Portelius collaborates with scholars based in Sweden, United Kingdom and United States. Erik Portelius's co-authors include Henrik Zetterberg, Kaj Blennow, Ulf Andréasson, Gunnar Brinkmalm, Ann Brinkmalm, Niklas Mattsson, Annika Öhrfelt, Maria Bjerke, Mikko Hölttä and Oskar Hansson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Erik Portelius

141 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

2016 1.4k citations Ulf Andréasson, Erik Portelius et al. profile →
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

2015 347 citations Henrik Zetterberg, Tobias Skillbäck et al. profile →

Peers

Countries citing papers authored by Erik Portelius

Since Specialization

Citations

This map shows the geographic impact of Erik Portelius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Portelius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Portelius more than expected).

Fields of papers citing papers by Erik Portelius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Portelius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Portelius. The network helps show where Erik Portelius may publish in the future.

Co-authorship network of co-authors of Erik Portelius

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Portelius. A scholar is included among the top collaborators of Erik Portelius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Portelius. Erik Portelius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Profiling amyloid‐β peptides as biomarkers for cerebral amyloid angiopathy 2024 ·Journal of Neurochemistry ·E. van den Berg, Iris Kersten, Gunnar Brinkmalm, (unknown), Anna M. de Kort, Catharina J.M. Klijn, Floris H.B.M. Schreuder, Johan Gobom, Erik Stoops, Erik Portelius, Eleni Gkanatsiou, Henrik Zetterberg, Kaj Blennow, H. Bea Kuiperij, Marcel M. Verbeek	3
2	Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer’s Disease 2023 ·Journal of Alzheimer s Disease ·E. van den Berg, Johanna Nilsson, Iris Kersten, Gunnar Brinkmalm, Anna M. de Kort, Catharina J.M. Klijn, Floris H.B.M. Schreuder, Lieke Jäkel, Johan Gobom, Erik Portelius, Henrik Zetterberg, Ann Brinkmalm, Kaj Blennow, H. Bea Kuiperij, Marcel M. Verbeek	4
3	Genetic mapping of APP and amyloid‐β biology modulation by trisomy 21 2023 ·Alzheimer s & Dementia ·Paige Mumford, Justin Tosh, (unknown), Eleni Gkanatsiou, (unknown), Suzanna Noy, Karen Cleverley, Takashi Saito, Takaomi C. Saido, Eugene Yu, Gunnar Brinkmalm, Erik Portelius, Kaj Blennow, Henrik Zetterberg, Victor L. J. Tybulewicz, Elizabeth Fisher, Frances K. Wiseman	0
4	Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease 2022 ·Alzheimer s Research & Therapy ·Johanna Nilsson, Nicholas J. Ashton, Andréa Lessa Benedet, Laia Montoliu‐Gaya, Johan Gobom, Tharick A. Pascoal, Mira Chamoun, Erik Portelius, Andreas Jeromin, (unknown), Henrik Zetterberg, Pedro Rosa‐Neto, Ann Brinkmalm, Kaj Blennow	22
5	Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics 2021 ·Scientific Reports ·(unknown), Fani Pujol-Calderón, (unknown), Anna Wuolikainen, Kina Höglund, Karin Forsberg, Erik Portelius, Kaj Blennow, Henrik Zetterberg, Peter M. Andersen	52
6	Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg 2020 ·Alzheimer s Research & Therapy ·(unknown), Ayesha Khatun, (unknown), Konstantin Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, Ulf Andréasson, Erik Portelius, Nicholas J. Ashton, Kaj Blennow, Michael Schöll, Ross W. Paterson, Jonathan M. Schott, Henrik Zetterberg	35
7	Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury 2020 ·Scientific Reports ·Karolina Minta, Gunnar Brinkmalm, Faiez Al Nimer, Eric Peter Thelin, Fredrik Piehl, Mats Tullberg, Anna Jeppsson, Erik Portelius, Henrik Zetterberg, Kaj Blennow, Ulf Andréasson	25
8	Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta 2019 ·Molecular Psychiatry ·Charles Arber, Jamie Toombs, Christopher Lovejoy, Natalie S. Ryan, Ross W. Paterson, Nanet Willumsen, Eleni Gkanatsiou, Erik Portelius, Kaj Blennow, Amanda Heslegrave, Jonathan M. Schott, John Hardy, Tammaryn Lashley, Nick C. Fox, Henrik Zetterberg, Selina Wray	98
9	Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments 2019 ·PLoS ONE ·Marianne Grant, (unknown), Małgorzata Rózga, Gunnar Brinkmalm, Erik Portelius, Kaj Blennow, Karen H. Ashe, Kathleen R. Zahs, Peng Liu	11
10	The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease 2018 ·Acta Neuropathologica ·Hlin Kvartsberg, Tammaryn Lashley, Christina E. Murray, Gunnar Brinkmalm, Nicholas Cullen, Kina Höglund, Henrik Zetterberg, Kaj Blennow, Erik Portelius	67
11	The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease 2018 ·Acta Neuropathologica Communications ·Christina E. Murray, Priya Gami‐Patel, Eleni Gkanatsiou, Gunnar Brinkmalm, Erik Portelius, Oliver Wirths, Wendy Heywood, Kaj Blennow, Jorge Ghiso, Janice L. Holton, Kevin Mills, Henrik Zetterberg, Tamás Révész, Tammaryn Lashley	12
12	Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease 2015 ·Alzheimer s Research & Therapy ·(unknown), Hlin Kvartsberg, Erik Portelius, Ulf Andréasson, Timo Jan Oberstein, Piotr Lewczuk, Kaj Blennow, Johannes Kornhuber, Juan Manuel Maler, Henrik Zetterberg, Philipp Spitzer	109
13	P1‐010: Quantification of the synaptic protein neurogranin in cerebrospinal fluid across different neurodegenerative diseases: A selective Alzheimer's disease biomarker? 2015 ·Alzheimer s & Dementia ·Henrietta Wellington, Ulrika Törnqvist, Erik Portelius, Ross W. Paterson, Nadia Magdalinou, Nick C. Fox, Kaj Blennow, Jonathan M. Schott, Henrik Zetterberg	2
14	APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment 2015 ·Alzheimer s Research & Therapy ·Simon Sjödin, (unknown), Marc Mercken, Henrik Zetterberg, Herman Borghys, Kaj Blennow, Erik Portelius	8
15	Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease 2015 ·Brain ·Erik Portelius, Henrik Zetterberg, Tobias Skillbäck, Ulrika Törnqvist, Ulf Andréasson, John Q. Trojanowski, Michael W. Weiner, Leslie M. Shaw, Niklas Mattsson	201
16	Second Generation γ-Secretase Modulators Exhibit Different Modulation of Notch β and Aβ Production 2012 ·Journal of Biological Chemistry ·Johanna Wanngren, (unknown), Santiago Parpal, Erik Portelius, Kia Strömberg, (unknown), Rebecka Klintenberg, Anders Juréus, (unknown), Kaj Blennow, Henrik Zetterberg, Johan Lundkvist, Susanne Rosqvist, Helena Karlström	19
17	Multiplexing and multivariate analysis in neurodegeneration 2012 ·Methods ·Ulf Andréasson, Erik Portelius, Josef Pannee, Henrik Zetterberg, Kaj Blennow	11
18	Identification of Novel APP/Aβ Isoforms in Human Cerebrospinal Fluid 2009 ·Neurodegenerative Diseases ·Erik Portelius, Gunnar Brinkmalm, (unknown), Henrik Zetterberg, Ann Brinkmalm, Kaj Blennow	61
19	A novel pathway for amyloid precursor protein processing 2009 ·Neurobiology of Aging ·Erik Portelius, Eric A. Price, Gunnar Brinkmalm, (unknown), Maria Olsson, Rita Persson, Ann Brinkmalm, Henrik Zetterberg, Adam J. Simon, Kaj Blennow	135
20	Evaluation of sample fractionation using micro‐scale liquid‐phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment 2007 ·Rapid Communications in Mass Spectrometry ·Annika Thorsell, Erik Portelius, Kaj Blennow, Ann Brinkmalm	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact